Clinical trial · Observational
Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer
Patient-partnered Research: a Key to Investigating Fear of Cancer Recurrence in Patients With Surgically Treated Kidney Cancer (PP-RECURK)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to gather real-world information about Fear of Cancer Recurrence (FCR) following surgery in patients with renal cell carcinoma (RCC) and their partners/spouses by 1) establishing a panel consisting of patients with or without partners/spouses to facilitate patient-partnered research. Furthermore, 2) Through discussions among panel members and researchers identification of the most pertinent topics related to FCR, as well as the optimal timing and methods for collecting that information in the follow-up care after surgery. Finally, to conduct a feasibility and pilot study to investigate the feasibility of the recommendations developed in 1) + 2) and assess FCR in patients with RCC following surgery and their partners/spouses. In phase 1 participants (panel members) will be asked to collaborate with researchers in the development of recommendations for FCR questions, mode of administration and timing in the follow-up care after surgically treated kidney cancer. In phase 2 participants (patients and partners) in follow-up care after surgically treated kidney cancer are asked to answer questions about FCR at specific timepoints defined by panel members and researchers in phase 1.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fear of Cancer Recurrence | Kidney Neoplasm | PROBABILISTIC | 0.70 |
| Renal Cell Carcinoma (Kidney Cancer) | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Phase 1: Establishment of a patient-partner panel | Other | — | UNRESOLVED |
| Phase 2: Feasibility testing of FCR questions, mode of administration and timing for investigating Fear of Cancer Recurrence | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Panel members
- description
- 6 patients with spouses/partners and 3 single patients. In total 15 subjects.
- interventionNames
- Other: Phase 1: Establishment of a patient-partner panel
- label
- Pilot population
- description
- In total 90 subjects (patients with or without partners)
- interventionNames
- Other: Phase 2: Feasibility testing of FCR questions, mode of administration and timing for investigating Fear of Cancer Recurrence
Primary outcomes (6)
- measure
- Phase 1: Assessment of the recruitment to and composition the patient-partner panel
- timeFrame
- From inclusion to week 16 or date of last subject included whichever comes first.
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: Phase 1: * Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse * Partner/spouse to patients who fullfil the inclusion criteria * Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor) * Time since surgery: 0-120 months * Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish * Patients/partners/spouses able to and willing to attend online project meetings or in person at Gødstrup Hospital. Phase 2: * Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse * Partner/spouse to patients who fullfill the inclusion criteria * Patients who have undergone surgery due to localized RCC (T1-T2-T3 tumor) * Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish * Able to receive digital communication from the hospital * Informed consent must be signed before answering Fear of Cancer Recurrence questions Exclusion Criteria: Both phases, both patients and partners/spouses: * Diagnosed with cognitive impairment * Untreated psychiatric disorders due to non-compliance Phase 2: • Patients and partners/spouses who were panelists in phase 1
References
Publications (7)
- BACKGROUNDHamilton CB, Hoens AM, McKinnon AM, McQuitty S, English K, Hawke LD, Li LC. Shortening and validation of the Patient Engagement In Research Scale (PEIRS) for measuring meaningful patient and family caregiver engagement. Health Expect. 2021 Jun;24(3):863-879. doi: 10.1111/hex.13227. Epub 2021 Mar 17. PMID 33729634
- BACKGROUNDGlasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999 Sep;89(9):1322-7. doi: 10.2105/ajph.89.9.1322. PMID 10474547
- BACKGROUNDRoberts JP, Fisher TR, Trowbridge MJ, Bent C. A design thinking framework for healthcare management and innovation. Healthc (Amst). 2016 Mar;4(1):11-4. doi: 10.1016/j.hjdsi.2015.12.002. Epub 2016 Jan 14. PMID 27001093
- BACKGROUNDAltman M, Huang TTK, Breland JY. Design Thinking in Health Care. Prev Chronic Dis. 2018 Sep 27;15:E117. doi: 10.5888/pcd15.180128. PMID 30264690
- BACKGROUNDSimard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009 Mar;17(3):241-51. doi: 10.1007/s00520-008-0444-y. Epub 2008 Apr 15. PMID 18414902
- BACKGROUNDSmith A', Wu VS, Lambert S, Lamarche J, Lebel S, Leske S, Girgis A. A systematic mixed studies review of fear of cancer recurrence in families and caregivers of adults diagnosed with cancer. J Cancer Surviv. 2022 Dec;16(6):1184-1219. doi: 10.1007/s11764-021-01109-4. Epub 2021 Nov 11. PMID 34762248
- BACKGROUNDBergerot CD, Battle D, Philip EJ, Bergerot PG, Msaouel P, Smith A', Bamgboje AE, Shuch B, Derweesh IH, Jonasch E, Stern AP, Pal SK, Staehler M. Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma. JCO Oncol Pract. 2020 Nov;16(11):e1264-e1271. doi: 10.1200/OP.20.00105. Epub 2020 Sep 18.